CHRONIC GRANULOMATOUS DISEASE
Clinical trials for CHRONIC GRANULOMATOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRANULOMATOUS DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRANULOMATOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for CGD: stem cell transplant breakthrough trial launches
⭐️ CURE ⭐️ Recruiting nowThis study tests whether adding special drugs (IL-6 and IFN-gamma blockers) to the standard stem cell transplant process can help more people with chronic granulomatous disease (CGD) get cured. CGD is a rare immune disorder that causes severe infections. The trial involves 50 peo…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ CURE ⭐️
Last updated May 14, 2026 12:02 UTC
-
Could a stem cell transplant tame severe immune disorders?
Disease control Recruiting nowThis study tests a stem cell transplant for people aged 5 to 40 with severe immune disorders like common variable immunodeficiency (CVID) or other conditions that cause the immune system to attack the body. The goal is to replace the faulty immune system with a healthy donor's st…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
MRNA 'Repair' for immune cells shows promise in rare infection disease
Disease control Recruiting nowThis early-stage study tests a new approach for chronic granulomatous disease (CGD), a genetic condition that leaves people unable to fight off infections. Researchers take a participant's own white blood cells, add a corrective mRNA instruction, and return the cells to the body.…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Gene therapy trial aims to fix immune system in rare disease
Disease control Recruiting nowThis study tests a gene therapy for chronic granulomatous disease (CGD), a rare immune disorder that causes severe infections. The treatment uses a modified virus to deliver a working copy of the faulty gene into the patient's own blood stem cells. Up to 10 participants of any ag…
Matched conditions: CHRONIC GRANULOMATOUS DISEASE
Phase: NA • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC